NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock
10.26 USD
+0.57 (+5.88%)
10.28 USD
+0.02 (+0.19%)
We assign a fundamental rating of 5 out of 10 to NUS. NUS was compared to 36 industry peers in the Personal Care Products industry. While NUS has a great health rating, its profitability is only average at the moment. NUS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
NUS had a positive operating cash flow in the past year.
NUS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NUS had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.69%, NUS is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
NUS has a better Return On Equity (13.70%) than 80.56% of its industry peers.
NUS has a Return On Invested Capital of 4.08%. This is comparable to the rest of the industry: NUS outperforms 55.56% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 11.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
NUS has a better Profit Margin (7.02%) than 75.00% of its industry peers.
With a Operating Margin value of 3.87%, NUS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of NUS has declined.
With a Gross Margin value of 67.20%, NUS perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
NUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NUS has more shares outstanding
Compared to 5 years ago, NUS has less shares outstanding
The debt/assets ratio for NUS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.75 indicates that NUS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.75, NUS is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
NUS has a better Debt to FCF ratio (4.29) than 83.33% of its industry peers.
NUS has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
NUS's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. NUS outperforms 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.75 |
ROIC/WACC0.49
WACC8.41%
2.3 Liquidity
NUS has a Current Ratio of 2.15. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.15, NUS is in line with its industry, outperforming 50.00% of the companies in the same industry.
NUS has a Quick Ratio of 1.45. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
NUS has a Quick ratio of 1.45. This is comparable to the rest of the industry: NUS outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.29%, which is quite impressive.
Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.85% on average per year.
The Revenue for NUS has decreased by -12.10% in the past year. This is quite bad
The Revenue has been decreasing by -6.47% on average over the past years.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
NUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.90% yearly.
The Revenue is expected to decrease by -5.77% on average over the next years.
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.43 indicates a rather cheap valuation of NUS.
NUS's Price/Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 91.67% of the companies in the same industry.
NUS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.87.
Based on the Price/Forward Earnings ratio of 7.15, the valuation of NUS can be described as very cheap.
NUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 88.89% of the companies in the same industry.
NUS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.43 | ||
| Fwd PE | 7.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaper than 94.44% of the companies in the same industry.
94.44% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.38 | ||
| EV/EBITDA | 3.85 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NUS's earnings are expected to grow with 29.90% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.49%, NUS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.09, NUS pays a bit more dividend than its industry peers.
NUS's Dividend Yield is a higher than the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NUS pays out 10.87% of its income as dividend. This is a sustainable payout ratio.
DP10.87%
EPS Next 2Y29.9%
EPS Next 3YN/A
10.26
+0.57 (+5.88%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners77.1%
Inst Owner Change0%
Ins Owners2.11%
Ins Owner Change-1.5%
Market Cap500.18M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %4.83%
Short Ratio5.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.43 | ||
| Fwd PE | 7.15 | ||
| P/S | 0.32 | ||
| P/FCF | 9.38 | ||
| P/OCF | 5.59 | ||
| P/B | 0.63 | ||
| P/tB | 0.74 | ||
| EV/EBITDA | 3.85 |
EPS(TTM)1.38
EY13.45%
EPS(NY)1.43
Fwd EY13.98%
FCF(TTM)1.09
FCFY10.67%
OCF(TTM)1.83
OCFY17.88%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.14
PEG (5Y)N/A
Graham Number22.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.75 |
F-Score6
WACC8.41%
ROIC/WACC0.49
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for NUS stock?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 7.43 and the Price/Book (PB) ratio is 0.63.
Can you provide the dividend sustainability for NUS stock?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 10.87%.